St. Jude Children's Research Hospital
St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family's ability to pay.
St. Jude treats children wtih cancer, blood disorders and related life-threatenting diseases. We take many of the toughest cases. This often includes children who do not respond well to standard treatments. View a list of diseases we treat.
At St. Jude Children's Research Hospital, science matters. From molecular breakthroughs to innovative therapies, our research discovers the cures of tomorrow, and saves children's lives today.
At St. Jude, we are committed to creating the next generation of scientific and clinical leaders.
Talented trainees come to St. Jude from top institutions around the world. We also share expertise with international health care professionals through our International Outreach Program.
Whether at school, at work or at play, you can support the lifesaving care of St. Jude the way you want.
Memphis, TN 38105
Unsure of his life’s direction, a young Danny Thomas sought guidance from St. Jude Thaddeus, the patron saint of hopeless causes. If the saint would point to the path he should take, Danny vowed to build a shrine in his name. Success followed Danny’s plea and soon after, the legendary entertainer set about fulfilling his vow to St. Jude. The result was St. Jude Children’s Research Hospital.
Danny Thomas officially opened St. Jude Children's Research Hospital on February 4, 1962, with the unveiling of the statue of St. Jude Thaddeus.
We've spent more than half a century finding cures and saving children, and our groundbreaking research has helped push the survival rate for childhood cancer from less than 20% in 1962 to more than 80% today.